Concepedia

R.H. Swift

RS

8

Publications

629

Citations

8

H-Index

1993

Active since

Affiliations

Pfizer (United States)(Current)

PRA Health Sciences

Sunovion (United States)

R.H. Swift is an author at Pfizer (United States) specializing in medicine, psychopathology, and neuropharmacology.

Top concepts

Publications per year

1993–2003

8

Publications

8

Intramuscular Ziprasidone, 2 mg Versus 10 mg, in the Short-Term Management of Agitated Psychotic Patients

Michael D. Lesem, John Zajecka, R.H. Swift et al. · The Journal of Clinical Psychiatry · 2001 · 220 citations

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

David G. Daniel, Steven G. Potkin, Karen R. Reeves et al. · Psychopharmacology · 2001 · 174 citations

, , +10

Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patients

R.H. Swift, Edmund P. Harrigan, Joseph C. Cappelleri et al. · Journal of Psychiatric Research · 2002 · 146 citations

, , +10

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy

David G. Daniel, Dan Zimbroff, R.H. Swift et al. · International Clinical Psychopharmacology · 2003 · 35 citations

Ipecacuanha-induced emesis: A human model for testing antiemetic drug activity

Neil Minton, R.H. Swift, Caroline Lawlor et al. · Clinical Pharmacology & Therapeutics · 1993 · 22 citations

Rows per page

1–5 of 8